BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 8351064)

  • 1. Goserelin treatment in glandular hyperplasia.
    Garozzo G; La Greca M; Lomeo E; Panella M
    Clin Exp Obstet Gynecol; 1993; 20(4):268-72. PubMed ID: 8281712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of GnRH agonists depot for the treatment of dysfunctional uterine bleeding.
    Colacurci N; De Placido G; Galasso M; Mollo A; Perino A; Cittadini E
    Acta Eur Fertil; 1991; 22(4):229-31. PubMed ID: 1844328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depot goserelin and danazol pre-treatment before rollerball endometrial ablation for menorrhagia.
    Fraser IS; Healy DL; Torode H; Song JY; Mamers P; Wilde F
    Obstet Gynecol; 1996 Apr; 87(4):544-50. PubMed ID: 8602306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term use of Goserelin depot in the treatment of dysfunctional uterine bleeding.
    Colacurci N; De Placido G; Mollo A; Perino A; Cittadini E
    Clin Exp Obstet Gynecol; 1995; 22(3):212-9. PubMed ID: 7554259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical effects of a 3-month formulation LH-RH agonist (Zoladex LA 10.8 mg depot) in patients with prostate cancer].
    Kotake T; Akaza H; Usami M; Naito S; Kanetake H; Taguchi T; Tsukagoshi S; Koiso K
    Hinyokika Kiyo; 2001 May; 47(5):349-61. PubMed ID: 11433759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new LH-RH agonist for treatment of prostate cancer, 3-month controlled-release formulation of goserelin acetate (Zoladex LA 10.8 mg depot)--outline of pre-clinical and clinical studies].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1675-87. PubMed ID: 12355959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of gestagens in prevention and therapy of endometrial hyperplasia].
    Römer T
    Zentralbl Gynakol; 1995; 117 Suppl():14-8. PubMed ID: 8571687
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cryoablation of endometrium in the treatment of pathological metrorrhagia].
    Zak H; Baranowski W
    Pol Merkur Lekarski; 2005 Nov; 19(113):716-8. PubMed ID: 16498819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pre-menopausal dysfunctional menometrorrhagia: therapeutic approach].
    Benedetto C; Giarola M; Marozio L; Zonca M; Micheletti L
    Minerva Ginecol; 1993 May; 45(5):223-33. PubMed ID: 8351060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The urban gynecologist and the management of menometrorrhagia: role of ultrasonography].
    Lavieille F
    Contracept Fertil Sex; 1998 Mar; 26(3):195-200. PubMed ID: 9592967
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of endometrial hyperplasia with Goserelin depot, an LH-RH analog].
    Pozzi M; Castagnola D; Cherubini F
    Minerva Ginecol; 1993 May; 45(5):251-4. PubMed ID: 8351064
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.